
Summit Therapeutics Inc
NASDAQ:SMMT

Wall Street
Price Targets
SMMT Price Targets Summary
Summit Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
SMMT
is 34.78 USD
with a low forecast of 12.12 USD and a high forecast of 46.2 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SMMT's stock price target?
Price Target
34.78
USD
According to Wall Street analysts, the average 1-year price target for
SMMT
is 34.78 USD
with a low forecast of 12.12 USD and a high forecast of 46.2 USD.